Newsletter Signup | Join Community
332
2
FDA Approves Venclexta, Daurismo, and Xospata Precision Cancer Medicines for Treatment of Acute Myeloid Leukemia
The 2nd generation TKI flumatinib appears to control CP-CML better than the historical standard of Gleevec.
ASCO updated reports Calquence has "clinically meaningful" benefit in CLL and may avoid some BTK associated side effects
Imbruvica® Rituxan combination superior to FCR chemotherapy for treatment of newly diagnosed CLL
Beth Israel Deaconess Medical Center doctors vaccine improves outcomes for patients suffering from AML
Quizartinib Improves Survival in Select Patients with Relapsed/Refractory Acute Myeloid Leukemia
CLL patients are at increased risk of developing a new cancer including those taking Ibrutinib & BTK Inhibitors
considering CAR T for ALL - anyone been through it yet?
looking for others to share their experience with stem cell transplant for leukemia.
